Dr Rhiannon Edge from Lancaster Medical School has been invited to the 68th Lindau Nobel Laureate Meeting.
The opportunity to join the annual gathering of Nobel Laureates in Germany is aimed at outstanding young scientists below the age of 35.
Rhiannon is one of only 600 students, doctoral candidates and post doctoral researchers from 84 countries to be chosen for this event, where she will meet 43 Nobel Laureates.
She said: "I am extremely excited to take part in the Lindau Nobel Laureate Meeting in June. I really believe that collaboration – engaging with scientists and researchers from a range of backgrounds – will best meet the challenges in health research, and ultimately improve public health.
"The Lindau Nobel Laureate Meeting will provide a unique opportunity to build relationships with world-leading researchers that I hope will lead to future working partnerships."
This year's meeting from June 24-29 is dedicated to physiology and medicine.
The Head of Lancaster Medical School Dr Rachel Isba said: "I am absolutely delighted that Rhiannon has been competitively selected to participate in this very prestigious international event. I am sure that she will be an excellent ambassador for the University and look forward to hearing about her experiences on her return."
The programme will for the first time feature so-called 'Agora Talks', in which Nobel Laureates answer the audience's questions.
In poster flashes and master classes, the young scientists will present their research to the Nobel Laureates and their colleagues.
Countess Bettina Bernadotte, President of the Council for the Lindau Nobel Laureate Meetings, said: "This summer we will once again welcome the next generation of top researchers."
Three newly minted Nobel Laureates will come to Lindau in 2018: the two biologists Michael Rosbash and Michael Young honoured for their role on the inner body clock, as well as the German-American chemist Joachim Frank.
Alongside the inner clock, the key topics of the 68th Lindau Meeting are the role of science today, gene therapy and scientific publishing practices.